Event to be held on December 6, 2023 will focus on preventing basal cell carcinomas associated with Gorlin syndrome with a discussion of the disease burden, SGT-610 and the upcoming Phase 3 trial NESS ZIONA, Israel,
cbdMD, Inc. (AMEX: YCBD), one of the nation's leading and widely recognized CBD companies, announced the release of the third product in its comprehensive NSF-Certified for Sport line of CBD products.